The health effects of diethylstilbestrol revisited

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 34, Issue 4, 2005, Pages 494-499

  Lauver, Diane ^a   Nelles, Kelly Kruse ^a   Hanson, Karen ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MERITER HOSPITAL   (United States)

Author keywords

Diethylstilbestrol (DES); Nursing implications; Screening (cancer and reproductive anomalies)

Indexed keywords

EID: 23644440106     PISSN: 08842175     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884217505278293     Document Type: Article

References (13)

1. Dieckmann, W. J., Davis, M. E., Rynkiewicz, L. M., Pottinger, R.E., & Gabbe, S. G. (1953). Does the administration of diethylstilbestrol during pregnancy have therapeutic value? American Journal of Obstetrics and Gynecology, 66, 1062-1075.
2. Giusti, R.M., Iwamoto, K., & Hatch, E.E. (1995). Diethylstilbesterol revisited: A review of the long-term health effects. Annals of Internal Medicine, 122(10), 778-788.
3. Goldberg, J.M., & Falcone, T. (1999). Effect of diethylstilbestrol on reproductive function. Fertility & Sterility, 72(1), 1-7.
4. Hatch, E.E., Palmer, J.R., Titus-Ernstoff, L., Noller K.L., Kaufman R.H., Mittendorf R., et al. (1998). Cancer risk in women exposed to diethylstilbestrol in utero. Journal of the American Medical Association, 280(7), 630-634.
5. Herbst, A.L. (2000). Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES). Gynecologic Oncology, 76, 147-156.
6. Kaufman, R.H. (Ed.). (1995). Recommendations for the identification and management of persons exposed to Diethylstilbestrol. Rockville, MD: National Cancer Institute.
7. Kaufman, R.H. (Ed.). (1995). Physician information: How to identify and manage DES exposed individuals. Bethesda: MD: National Cancer Institute.
8. Kaufman, R.H., Adam, E., Hatch, E.E., Noller, K., Herbst, A.L., Palmer, J.R., et al. (2000). Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstetrics & Gynecology, 96 (4), 483-489.
9. Laitman, C.J., Jonler, M., & Messing, E.M. (1997). The effects on men of prenatal exposure to diethylstilbestrol. In L. I. Lipshultz & S. S. Howards (Eds.), Infertility in the Male (3rd ed.) (pp. 268-279). St. Louis, MO: Mosby.
10. Newbold, R.R., Hanson, R.B., Jefferson, W.N., Bullock, B.C., & Haseman J. (1998). Increased tumors but compromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis, 19, 1655-1663.
11. Newbold, R.R., Hanson, R.B., Jefferson, W.N., Bullock, B.C., Haseman J., & McLachlan J.A. (2000). Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis, 21, 1355-1363.
12. Palmer, J.R., Anderson, D., Helmrich, S.P., & Herbst, A.L. (2000). Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma. Obstetrics & Gynecology, 95(6), 814-820.
13. Strohsnitter, W.C., Noller, K.L., Hoover, R.N., Robboy, S.J., Palmer, J.R., Titus-Ernstroff, L., et al. (2001). Cancer risk in men exposed in utero to diethylstilbestrol. Journal of the National Cancer Institute, 93(7), 545-551.